SF3B1 and chronic myelogenous leukemia, BCR-ABL1 positive: Mutations in SF3B1 have been implicated in myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML) and a number of late-stage cancers.